Mycobacterial Nucleic Acids Modulate Host Innate Immune Responses.

Autor: Srikrishna G; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA., Bullen CK; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA., Bishai WR; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, USA.

Publikováno v: Journal of infectious disease and therapy [J Infect Dis Ther] 2024; Vol. 12 (2). Date of Electronic Publication: 2024 Apr 11.

Intravenous BCG vaccination reduces SARS-CoV-2 severity and promotes extensive reprogramming of lung immune cells.

Autor: Singh AK; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Wang R; Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Lombardo KA; Johns Hopkins University, School of Medicine, Department of Urology, Baltimore, MD, USA., Praharaj M; Bloomberg∼Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD, USA., Bullen CK; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Um P; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Gupta M; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Srikrishna G; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Davis S; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Komm O; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Illei PB; Johns Hopkins University, School of Medicine, Department of Pathology, Baltimore, MD, USA., Ordonez AA; Johns Hopkins University, School of Medicine, Department of Pediatrics, Division of Infectious Diseases, Baltimore, MD, USA., Bahr M; Johns Hopkins University, School of Medicine, Department of Pediatrics, Division of Infectious Diseases, Baltimore, MD, USA., Huang J; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA., Gupta A; Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Psoter KJ; Johns Hopkins University, School of Medicine, Department of Pediatrics, Division of General Pediatrics, Baltimore, MD, USA., Creisher PS; Johns Hopkins University, Bloomberg School of Public Health, The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Baltimore, MD, USA., Li M; Johns Hopkins University, Bloomberg School of Public Health, The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Baltimore, MD, USA., Pekosz A; Johns Hopkins University, Bloomberg School of Public Health, The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Baltimore, MD, USA., Klein SL; Johns Hopkins University, Bloomberg School of Public Health, The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Baltimore, MD, USA., Jain SK; Johns Hopkins University, School of Medicine, Department of Pediatrics, Division of Infectious Diseases, Baltimore, MD, USA., Bivalacqua TJ; Perelman School of Medicine at the University of Pennsylvania, Division of Urology, Department of Surgery, Philadelphia, PA, USA., Yegnasubramanian S; Sydney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Bishai WR; Johns Hopkins University, School of Medicine, Department of Medicine, Center for Tuberculosis Research, Baltimore, MD, USA.

Publikováno v: IScience [iScience] 2023 Aug 24; Vol. 26 (10), pp. 107733. Date of Electronic Publication: 2023 Aug 24 (Print Publication: 2023).

Sulforaphane exhibits antiviral activity against pandemic SARS-CoV-2 and seasonal HCoV-OC43 coronaviruses in vitro and in mice.

Autor: Ordonez AA; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA. aordone2@jhmi.edu., Bullen CK; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Villabona-Rueda AF; Division of Pulmonology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Thompson EA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Turner ML; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Merino VF; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Yan Y; Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Kim J; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Davis SL; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Komm O; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Powell JD; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Bloomberg-Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA., D'Alessio FR; Division of Pulmonology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Yolken RH; Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jain SK; Division of Infectious Diseases, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jones-Brando L; Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA. lbrando@jhmi.edu.

Publikováno v: Communications biology [Commun Biol] 2022 Mar 18; Vol. 5 (1), pp. 242. Date of Electronic Publication: 2022 Mar 18.

Quantification of Infectious SARS-CoV-2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay.

Autor: Bullen CK; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. cbullen2@jh.edu., Davis SL; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Looney MM; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2452, pp. 131-146.

Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.

Autor: Durand CM; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney Kimmel Cancer Center, Baltimore, MD, USA. Electronic address: christinedurand@jhmi.edu., Capoferri AA; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Redd AD; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Zahurak M; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Rosenbloom DIS; Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co, Kenilworth, NJ, USA., Cash A; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Avery RK; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bolaños-Meade J; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Bollard CM; Sidney Kimmel Cancer Center, Baltimore, MD, USA; Program for Cell Enhancement and Technologies for Immunotherapy Children's National Health System, George Washington University Washington, DC, USA., Bullen CK; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Flexner C; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Fuchs EJ; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Gallant J; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Gilead Sciences, Foster City, CA, USA., Gladstone DE; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Gocke CD; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Jones RJ; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Kasamon YL; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Lai J; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Levis M; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Luznik L; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Marr KA; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Sidney Kimmel Cancer Center, Baltimore, MD, USA., McHugh HL; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Mehta Steinke S; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pham P; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pohlmeyer C; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pratz K; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Shoham S; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Wagner-Johnston N; Sidney Kimmel Cancer Center, Baltimore, MD, USA., Xu D; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Siliciano JD; Johns Hopkins University School of Medicine, Baltimore, MD, USA., Quinn TC; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Siliciano RF; Johns Hopkins University School of Medicine, Baltimore, MD, USA; Howard Hughes Medical Institute, Baltimore, MD, USA., Ambinder RF; Sidney Kimmel Cancer Center, Baltimore, MD, USA.

Publikováno v: The lancet. HIV [Lancet HIV] 2020 Sep; Vol. 7 (9), pp. e602-e610. Date of Electronic Publication: 2020 Jul 07.